Competing in the Global Cancer Diagnostics Market, 2017-2021

Date: June 20, 2017
Pages: 1200
Price:
US$ 32,500.00 US$ 26,000.00
Offer valid until December 31, 2017!
License [?]:
Publisher: Venture Planning Group
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: C9C17F638A8EN
Leaflet:

Download PDF Leaflet

Competing in the Global Cancer Diagnostics Market, 2017-2021
This new VPGMarketResearch.com comprehensive seven-country study identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends in the U. S. , five major European countries (France, Germany, Italy, Japan, UK) and Japan; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers. The new report contains 1,200 pages, 450 tables, and provides test volume and sales forecasts for major tumor markers, as well as supplier sales and shares by test, market segment and country. Available by country and section. Highlights- Identifies and evaluates major business opportunities emerging in the tumor marker market during the next five years - Examines trends in the U. S. , Europe and Japan - Reviews current and emerging tumor markers - Analyzes applications of emerging diagnostic technologies - Forecasts sales of major tumor markers by country and market segment - Profiles leading market players and potential entrants - Suggests alternative business expansion strategies for suppliers. RationaleThe cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide. Geographic Coverage- France - Germany - Italy - Japan - Spain - UK - USAMarket Segmentation Analysis- Sales and market shares of major suppliers, by individual tumor marker and country. - Five-year test volume and sales forecasts for major tumor markers by country and market segment, including:- Hospitals - Commercial/Private Laboratories - Physician Offices/Group Practices - Cancer Clinics - Ambulatory Care Centers- Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers by country. - Cancer statistics, etiology and recent developments in the U. S. , Japan and five major European countries. Current and Emerging Products- Review of over 200 current and emerging tumor markers, including:- Biochemical Markers - Oncogenes - Growth Factors - Hormones - Colony Stimulating Factors - Lymphokines - Immunohistochemical Stains, and others. - Analysis of major immunoassay analyzers used for tumor marker testing, including their operating characteristics, features and selling prices. Technology Review- Assessment of monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, artificial intelligence, flow cytometry, biosensors, and their potential applications for tumor marker testing. - Review of competing/complementing technologies, including CT, MRI, NMR, PET and photonics spectroscopy. - Extensive listings of over 500 companies, universities and research centers developing new tumor markers and detection technologies. Competitive Assessments- Extensive strategic assessments of major suppliers and start-up firms developing innovative technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D. Worldwide Market Overview- Estimated universe of laboratories performing tumor marker testing by country. - Five-year test volume and sales projections by country. Business Opportunities and Strategic Recommendations- Specific new product development opportunities with potentially significant market appeal during the next five years. - Design criteria for new products. - Alternative market penetration strategies. - Potential market entry barriers and risks. MethodologyThis report is based on interviews with clinical pathologists, laboratory directors, executives from leading diagnostic companies and start-up firms developing innovative products, university scientists, as well as experts from industry associations, venture capital firms and the investment banking community in the U. S. , five major European countries and Japan. The market projections are also based on questionnaire responses received from hospitals, commercial/private laboratories, physician offices/group practices, cancer clinics and ambulatory care centers in seven countries. In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product literature, patents, trade association surveys, government studies, marketing and technical meeting presentations, industry analyst reports, and VPGMarketResearch.com's proprietary data files was conducted.

Contains 1,200 pages and 450 tables
1. INTRODUCTION

2. WORLDWIDE MARKET OVERVIEW

  1. MARKET OVERVIEW
  2. WORLDWIDE MARKET STRUCTURE
  3. WORLDWIDE MARKET SIZE AND GROWTH

3. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products

4. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

5. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies

6. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

7. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Cancer Statistics and Etiology
  1. BREAST CANCER
  2. LUNG CANCER
  3. COLON AND RECTUM CANCER
  4. PROSTATE CANCER
  5. STOMACH CANCER
  6. LEUKEMIA
  7. LYMPHOMA
  8. ORAL CANCER
  9. SKIN CANCER
  10. UTERINE CANCER
  11. OVARIAN CANCER
  12. BLADDER CANCER
B. Major Current And Emerging Cancer Diagnostic Tests
  1. INTRODUCTION
  2. TUMOR MARKER CLASSIFICATION
  3. ACTH
  4. ALPHA FETOPROTEIN (AFP)
  5. BETA 2 MICROGLOBULIN
  6. CA 15 3/27.29
  7. CA 199
  8. CA 125
  9. CALCITONIN
  10. CARCINOEMBRIONIC ANTIGEN (CEA)
  11. ESTROGEN AND PROGESTERONE RECEPTORS
  12. FERRITIN
  13. GASTRIN
  14. HUMAN CHORIONIC GONADOTROPIN (HCG)
  15. INSULIN
  16. NSE
  17. OCCULT BLOOD
  18. PAP SMEAR/HPV
  19. PROSTATIC ACID PHOSPHATASE (PAP)
  20. PROSTATE    SPECIFIC ANTIGEN (PSA)
  21. SQUAMOUS CELL CARCINOMA ANTIGEN (SCC)
  22. T AND B LYMPHOCYTES
  23. TDT
  24. THYROGLOBULIN
  25. TISSUE POLYPEPTIDE ANTIGEN (TPA)
  26. BIOCHEMICAL TUMOR MARKERS
  27. ONCOGENES
  Abl/abl bcr
  AIB1
  BCL2
  BRCA1
  CD44
  C-fos
  C-myb
  C-myc
  CYP    17
  ErbB
  HPC1
  Nmyc
  P40
  P51
  P53
  PIK3CA
  PTI1
  Ras
  Reg
  Sis
  Src
  28. POLYPEPTIDE GROWTH FACTORS
  Basic Fibroblast Growth Factor
  Beta    TGF
  Cachectin (TNT)
  Calmodulin
  ECFR
  Nerve Growth Factor (NGF)
  Epidermal Growth Factor (EGF)
  Ornithine Decarboxylase
  Transferrin
  Transforming Growth Factor    Alpha
  29. ECTOPIC HORMONES
  30. COLONY STIMULATING FACTORS
  31. LYMPHOKINES
  Alpha    Interferon
  B Cell Growth Factors
  B Cell Growth Factor (BCGF)
  Gamma    Interferon
  Interleukin    1 (IL1)
  Macrophage Activating Factor
  32. IMMUNOHISTOCHEMICAL STAINS
  33. EMERGING TUMOR MARKERS
  NAcetylglucosamine
  Actin
  Alpha    Actin
  Antineuronal Antibodies
  7B2
  B72.3
  Bax
  BCD    F9
  BLCA 4
  Blood Group Antigens A, B, H
  CA
  CA 72    4/TAG    72
  CA
  CA 242
  CA 549
  CAM
  CAR    3
  Cathepsin    D
  Chromogranin A and B
  Cluster 1 Antigen
  Cluster    5/5A Antigen
  CTA
  CU18
  DR    70
  DU    AN2
  Endometrial Bleeding Associated Factor
  Endostatin
  Epithelial Membrane Antigen
  Feulgen Hydrolysis
  Fibronectin
  FSH
  (1    >3)    Lfucosyltransferase
  Gastrin    Releasing Peptide (GRP)
  GDCFP    15
  Glucagon
  Glycoamines
  H23
  Her    2
  Human Carcinoma Antigen
  HPA
  HSP27
  Intermediate Filaments
  Cytokeratins/CK18/Cyfra 21    1
  Desmin
  Gliofibrillary Acid Protein
  Neurofilaments
  Vimentin
  KA
  Kinases
  KP16D3
  LAI
  Leukocyte Common Antigen
  Lewis Antigens
  Lysophosphatidic Acid (LPA)
  Ma 695/Ma
  MABDF3
  MAG
  ME1
  Minactivin
  MN/CA9
  MSA
  Mucin Cancer Antigen (MCA)
  Multiple Tumor Suppressor
  Myosin
  NEA 130
  NMP22
  OA 519
  Opioid Peptides
  P    glycoprotein
  Pancreatic Oncofetal Antigen (POA)
  Placental Lactogen
  PR92
  Proliferative Index, Ki 67
  Px
  RB Inactivation/Deletion
  Ret
  SCCL
  Selectin
  Sialic Acid
  Sialyl SSEA 1/SLX
  SN10
  Somatostatin
  TA 90
  TABA
  Tachykinin
  TAG
  TPS
  Troponin
  Tubulin
  VCAM
  VEGF
  Villen
C. Cancer Diagnostic Testing Instrumentation Review and Market Needs
D. Current and Emerging Cancer Diagnostic Technologies
  1. MONOCLONAL AND POLYCLONAL ANTIBODIES
  2. IMMUNOASSAYS
  3. MOLECULAR DIAGNOSTICS
  4. CHROMOSOME ANALYSIS
    a. Chronic Myelogenous Leukemia (CML)
    b. Acute Myeloid Leukemia (AML)
    c. Acute Lymphoblastic Leukemia (ALL)
    d. Malignant Lymphomas Lymphoid Malignancies
    e. Chronic Lymphocytic Leukemia (CLL)
    f. Solid Cancers
    g. Chromosomal Translocation and Oncogenes
  5. ARTIFICIAL INTELLIGENCE
  6. FLOW CYTOMETRY
  7. TW DIMENSIONAL GEL ELECTROPHORESIS (2    DGE)
  8. BIOSENSORS
  9. COMPETING/COMPLEMENTING TECHNOLOGIES
E. Personal Testing

8. FRANCE CANCER DIAGNOSTICS MARKET

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test

9. GERMANY CANCER DIAGNOSTICS MARKET

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test

10. ITALY CANCER DIAGNOSTICS MARKET

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test

11. JAPAN CANCER DIAGNOSTICS MARKET

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test

12. SPAIN CANCER DIAGNOSTICS MARKET

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test

13. U.K. CANCER DIAGNOSTICS MARKET

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test

14. U.S. CANCER DIAGNOSTICS MARKET

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test

15. COMPETITIVE PROFILES

  Abbott
  AdnaGen/Alere
  Agilent Technologies
  Applied Gene Technologies
  Arca Biopharma
  Beckman Coulter/Danaher
  Becton Dickinson
  Biomedical Diagnostics
  bioMerieux
  Bio-Rad
  CellSearch
  Cepheid
  Correlogic Systems/Vermillion
  Decode Genetics
  Diadexus
  Diagnocure
  Diasorin
  Eiken Chemical
  Elitech Group
  Enterix
  Enzo Biochem
  Epigenomics
  Exact Sciences
  Fujirebio
  Guided Therapeutics
  Hologic/Genrobe
  Kreatech/Leica
  Kyowa Medex
  Mackay Life Sciences
  Myriad Genetics
  OncoLab
  Ortho    Clinical Diagnostics
  Panacea Pharmaceuticals
  Polartechnics
  Polymedco
  PreMD
  Qiagen
  Quest Diagnostics
  Radient Pharmaceuticals
  Roche
  Scienion
  Sequenom
  Siemens Healthcare
  Takara Bio
  Targeted Diagnostics & Therapeutics
  Tosoh
  Thermo
  Veridex
  Wako Pure Chemicals
  Wallac/PE
  Zila

16. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING CANCER DIAGNOSTIC TECHNOLOGIES AND APPLICATIONS

LIST OF TABLES

Tumor Marker Classification
Major Companies Developing or Marketing ACTH Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing Beta    2 Microglobulin Tests
Major Companies Developing or Marketing CA 15 3/27.29 Tests
Major Companies Developing or Marketing CA 199 Tests
Major Companies Developing or Marketing CA 125 Tests
Major Companies Developing or Marketing Calcitonin Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Estrogen Receptor Tests
Major Companies Developing or Marketing Progesterone Receptor Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing Gastrin Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing Insulin Tests
Major Companies Developing or Marketing NSE Tests
Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing PAP Smear/HPV Tests
Major Companies Developing or Marketing PAP Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications In Cancer Diagnosis
Oncogenes Potential Applications In Cancer Diagnosis
Major Companies Developing or Marketing Oncogene Tests
Growth Factors Potential Applications In Cancer Diagnosis
Colony Stimulating Factors Potential Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis
Immunohistochemical Stains Potential Applications in Cancer Diagnosis
Executive Summary Table: France, Total Cancer Diagnostic Test Volume and Sales Forecast by Market Segment
France, Estimated Cancer Death Rates Per 100, 000 Population
France, Laboratories Performing Tumor Marker Tests by Market Segment
France, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
France, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
France, Total Tumor Marker Test Volume Forecast by Market Segment
France, All Market Segments Major Tumor Marker Test Volume Forecast
France, Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
France, Commercial/Private Laboratories Marker Test Volume Forecast
France, Total Tumor Marker Sales Major Tumor Forecast by Market Segment
France, All Market Segments Major Tumor Marker Sales Forecast by Test
France, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
France, Commercial/Private Laboratories Cancer
Diagnostics Market Forecast by Test
France, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
France, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
France, Beta    2 Microglobulin Test Volumeand Diagnostics Sales Forecast by Market Segment
France, CA 15 3/27.29 Test Volumeand Diagnostics Sales Forecast by Market Segment
France, CA 199 Test Volume and Diagnostics Sales Forecast by Market
France, CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment
France, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
France, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
France, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
France, Colon    Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
France, Cytokeratins Test Volumeand Diagnostics Sales Forecast by Market Segment
France, Estrogen Receptor Test Volumeand Diagnostics Sales Forecast by Market Segment
France, Ferritin Test Volumeand Diagnostics Sales Forecast by Market Segment
France, Gastrin Test Volumeand Diagnostics Sales Forecast by Market Segment
France, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
France, Insulin Test Volumeand Diagnostics Sales Forecast by Market Segment
France, Interferons Test Volumeand Diagnostics Sales Forecast by Market Segment
France, Interleukins Test Volumeand Diagnostics Sales Forecast by Market Segment
France, Lymphocyte Subtyping Test Volume And Diagnostics Sales Forecast by Market Segment
France, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
France, Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment
France, Occult Blood Test Volumeand Diagnostics Sales Forecast by Market Segment
France, Oncogenes Test Volumeand Diagnostics Sales Forecast by Market Segment
France, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
France, PAP Smear Test Volumeand Diagnostics Sales Forecast by Market Segment
France, Parathyroid Hormone Test Volumeand Diagnostics Sales Forecast by Market Segment
France, Progesterone Receptor Test Volume And Diagnostics Sales Forecast by Market Segment
France, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
France, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
France, S    100 Protein Test Volume and Sales Diagnostics Sales Forecast by Market Segment
France, Serotonin Test Volumeand Diagnostics Sales Forecast by Market Segment
France, Sialic Acid Test Volumeand Diagnostics Sales Forecast by Market Segment
France, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
France, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
France, Thymidine Kinase Test Volume And Diagnostics Sales Forecast by Market Segment
France, Thyroglobulin Test Volumeand Diagnostics Sales Forecast by Market Segment
France, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
France, Total Tumor Marker Sales By Major Suppliers
France, AFP Testing Market Diagnostics Sales by Major Supplier
France, CA 15 3 Testing Market Diagnostics Sales by Major Supplier
France, CA 199 Testing Market Diagnostics Sales by Major Supplier
France, CA 125 Testing Market Diagnostics Sales by Major Supplier
France, CEA Testing Market Diagnostics Sales by Major Supplier
France, NSE Testing Market Diagnostics Sales by Major Supplier
France, PAP Testing Market Diagnostics Sales by Major Supplier
France, PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table: Germany, Total Tumor Marker Test Volume and Sales Forecast By Market Segment
Germany, Estimated Cancer Death Rates Per 100, 000 Population
Germany, Laboratories Performing Tumor Marker Tests by Market Segment
Germany, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
Germany, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
Germany, Total Tumor Marker Test Volume Forecast by Market Segment
Germany, All Market Segments, Major Tumor Marker Test Volume Forecast
Germany, Hospital Laboratories, Major Tumor Marker Test Volume Forecast by Test
Germany, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
Germany, Physician Offices/Group Practices Major Tumor Marker Test Volume Forecast
Germany, Total Tumor Marker Sales Forecast by Market Segment
Germany, All Market Segments Major Tumor Marker Sales Forecast by Test
Germany, Hospital Laboratories, Major Tumor Marker Sales Forecast by Test
Germany, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
Germany, Physician Offices/Group Practices Major Tumor Marker Sales Forecast by Test
Germany, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Beta    2 Microglobulin Test Volume And Diagnostics Sales Forecast by Market Segment
Germany, CA 15 3/27.29 Test Volumeand Diagnostics Sales Forecast by Market Segment
Germany, CA 19 Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Calcitonin Test Volume And Diagnostic Sales Forecast by Market Segment
Germany, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Chromogranin Test Volume And Diagnostics Sales Forecast by Market Segment
Germany, Colon    Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
Germany, Cytokeratins Test Volumeand Diagnostics Sales Forecast by Market Segment
Germany, Estrogen Receptor Test Volumeand Diagnostics Sales Forecast by Market Segment
Germany, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, HCG, Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Interferons Test Volumeand Diagnostics Sales Forecast by Market Segment
Germany, Interleukins Test Volumeand Diagnostics Sales Forecast by Market Segment
Germany, Lymphocyte Subtyping Test Volumeand Diagnostics Sales Forecast by Market Segment
Germany, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Occult Blood Test Volumeand Diagnostics Sales Forecast by Market Segment
Germany, Oncogenes Test Volumeand Diagnostics Sales Forecast by Market Segment
Germany, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Pap Smear Test Volumeand Diagnostics Sales Forecast by Market Segment
Germany, Parathyroid Hormone Test Volumeand Diagnostics Sales Forecast by Market Segment
Germany, Progesterone Receptor Test Volume And Diagnostics Sales Forecast by Market Segment
Germany, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, S    100 Protein Test Volumeand Diagnostics Sales Forecast by Market Segment
Germany, Serotonin Test Volumeand Diagnostics Sales Forecast by Market Segment
Germany, Sialic Acid Test Volumeand Diagnostics Sales Forecast by Market Segment
Germany, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast By Market Segment
Germany, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Thymidine Kinase Test Volumeand Diagnostics Sales Forecast by Market Segment
Germany, Thyroglobulin Test Volumeand Diagnostics Sales Forecast by Market Segment
Germany, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
Germany, Total Tumor Marker Sales By Major Supplier
Germany, AFP Testing Market Diagnostics Sales by Major Supplier
Germany CA 15 3/27.29 Testing Market Diagnostics Sales by Major Supplier
Germany CA 199 Testing Market Diagnostics Sales by Major Supplier
Germany, CA 125 Testing Market Diagnostics Sales by Major Supplier
Germany, CEA Testing Market Diagnostics Sales by Major Supplier
Germany, PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table: Italy, Total Tumor Marker Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Estimated Cancer Death Rates Per 100, 000 Population
Italy, Laboratories Performing Tumor Marker Tests by Market Segment
Italy, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
Italy, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
Italy, Total Tumor Marker Test Volume Forecast by Market Segment
Italy, All Market Segments Major Cancer Diagnostic Test Volume Forecast
Italy, Hospital Laboratories Major Tumor Marker Test Volume Forecast
Italy, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
Italy, Total Tumor Marker Test Market Forecast by Market Segment
Italy, All Market Segments Major Tumor Marker Sales Forecast by Test
Italy, Hospital Laboratories Major Tumor Marker Forecast by Test
Italy, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
Italy, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Beta    2 Microglobulin Test Volume And Diagnostics Sales Forecast by Market Segment
Italy, CA 15 3/27.29 Test Volumeand Diagnostics Sales Forecast by Market Segment
Italy, CA 199 Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Chromogranin Test Volume And Diagnostics Sales Forecast by Market Segment
Italy, Colon Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
Italy, Cytokeratins Test Volumeand Diagnostics Sales Forecast by Market Segment
Italy, Estrogen Receptor Test Volumeand Diagnostics Sales Forecast by Market Segment
Italy, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Lymphocyte Subtyping Test Volume And Diagnostics Sales Forecast by Market Segment
Italy, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast By Market Segment
Italy, PAP Smear Test Volumeand Diagnostics Sales Forecast by Market Segment
Italy, Parathyroid Hormone Test Volumeand Diagnostics Sales Forecast by Market Segment
Italy, Progesterone Receptor Test Volumeand Diagnostics Sales Forecast by Market Segment
Italy, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, S    100 Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Serotonin Test Volumeand Diagnostics Sales Forecast by Market Segment
Italy, Sialic Acid Test Volumeand Diagnostics Sales Forecast by Market Segment
Italy, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast By Market Segment
Italy, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Thymidine Kinase Test Volumeand Diagnostics Sales Forecast by Market Segment
Italy, Thyroglobulin Test Volumeand Diagnostics Sales Forecast by Market Segment
Italy, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
Italy, Total Tumor Markers Sales by Major Suppliers
Italy, AFP Testing Market Diagnostics Sales by Major Supplier
Italy, CEA Testing Market Diagnostics Sales by Major Supplier
Italy, PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table: Japan, Total Tumor Marker Test Volume and Sales Forecast by Market Segment
Japan, Estimated Cancer Death Rates Per 100, 000 Population
Japan, Laboratories Performing Tumor Marker Tests by Market Segment
Japan, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
Japan, Commercial/Private Laboratories Performing Tumor Marker Tests By Annual Test Volume
Japan, Total Tumor Marker Testing Volume Forecast by Market Segment
Japan, All Market Segments Major Tumor Marker Test Volume Forecast
Japan, Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
Japan, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
Japan, Total Tumor Marker Sales Forecast by Market Segment
Japan, All Market Segments Major Tumor Marker Sales Forecast by Test
Japan, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
Japan, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
Japan, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Beta    2 Microglobulin Test Volumeand Diagnostics Sales Forecast by Market Segment
Japan, CA 15 3/27.29 Test Volumeand Diagnostics Sales Forecast by Market Segment
Japan, CA 199 Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Chromogranin Test Volumeand Diagnostics Sales Forecast by Market Segment
Japan, Colon    Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
Japan, Cytokeratins Test Volumeand Diagnostics Sales Forecast by Market Segment
Japan, Estrogen Receptor Test Volumeand Diagnostics Sales Forecast by Market Segment
Japan, Ferritin Test Volumeand Diagnostics Sales Forecast by Market Segment
Japan, Gastrin Test Volumeand Diagnostics Sales Forecast by Market Segment
Japan, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Interferons Test Volumeand Diagnostics Sales Forecast by Market Segment
Japan, Interleukins Test Volumeand Diagnostics Sales Forecast by Market Segment
Japan, Lymphocyte Subtyping Test Volumeand Diagnostics Sales Forecast by Market Segment
Japan, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Nucleolar Test Volumeand Diagnostics Sales Forecast by Market Segment
Japan, Occult Blood Test Volumeand Diagnostics Sales Forecast by Market Segment
Japan, Oncogenes Test Volumeand Diagnostics Sales Forecast by Market Segment
Japan, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, PAP Smear Test Volumeand Diagnostics Sales Forecast by Market Segment
Japan, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, S    100 Protein Test Volumeand Diagnostics Sales Forecast by Market Segment
Japan, Serotonin Test Volumeand Diagnostics Sales Forecast by Market Segment
Japan, Sialic Acid Test Volumeand Diagnostics Sales Forecast by Market Segment
Japan, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
Japan, TPA, Test Volume and Diagnostics Sales Forecast by Market Segment
`Japan, Total Tumor Marker Sales by Major Suppliers
Japan, AFP Testing Market Diagnostics Sales by Major Supplier
Japan, CA 15 3/27.29 Testing Market Diagnostics Sales by Major Supplier
Japan, CA 199 Testing Market Diagnostics Sales by Major Supplier
Japan, CA 125 Testing Market Diagnostics Sales by Major Supplier
Japan, Calcitonin Testing Market Diagnostics Sales by Major Supplier
Japan, PAP Testing Market Diagnostics Sales by Major Supplier
Japan, PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table: Spain, Total Tumor Marker Test Volume and Sales Forecast by Market Segment
Spain, Estimated Cancer Death Rates Per 100, 000 Population
Spain, Laboratories Performing Tumor Marker Tests by Market Segment
Spain, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
Spain, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
Spain, Total Tumor Marker Test Volume Forecast by Market Segment
Spain, All Market Segment Major Cancer Diagnostic Test Volume Forecast
Spain, Hospital Laboratories Major Cancer Diagnostic Test Volume Forecast by Test
Spain, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
Spain, Total Tumor Marker Sales Forecast by Market Segment
Spain, All Market Segments Major Tumor Marker Sales Forecast by Test
Spain, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
Spain, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
Spain, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Beta    2 Microglobulin Test Volumeand Diagnostics Sales Forecast by Market Segment
Spain, CA 15 3 Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, CA 199 Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Colon    Specific Antigen Test Volumeand Diagnostics Sales Forecast by Market Segment
Spain, Estrogen Receptor Test Volumeand Diagnostics Sales Forecast by Market Segment
Spain, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Occult Blood Test Volumeand Diagnostics Sales Forecast by Market Segment
Spain, Oncogenes Test Volumeand Diagnostics Sales Forecast by Market Segment
Spain, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, PAP Smear Test Volumeand Diagnostics Sales Forecast by Market Segment
Spain, Parathyroid Hormone Test Volume And Diagnostics Sales Forecast by Market Segment
Spain, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, S    100 Protein Test Volume And Diagnostics Sales Forecast by Market Segment
Spain, Serotonin Test Volumeand Diagnostics Sales Forecast by Market Segment
Spain, Sialic Acid Test Volumeand Diagnostics Sales Forecast by Market Segment
Spain, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Total Tumor Marker Sales by Major Suppliers
Spain, AFP Testing Market Diagnostics Sales by Major Supplier
Spain, CA 15 3/27.29 Testing Market Diagnostics Sales by Major Supplier
Spain, 199 Testing Market Diagnostics Sales by Major Supplier
Spain, CA 125 Testing Market Diagnostics Sales by Major Supplier
Spain, CEA Testing Market Diagnostics Sales by Major Supplier
Spain, PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table: U.K., Total Tumor Marker Test Volume and Sales Forecast by Market Segment
U.K., Estimated Cancer Death Rates Per 100, 000 Population
U.K., Laboratories Performing Tumor Marker Tests by Market Segment
U.K., Hospital Laboratories Performing Tumor Marker Tests by Bed Size
U.K., Commercial/Private Laboratories Performing Tumor Marker Tests by Annual Test Volume
U.K., Total Tumor Marker Testing Volume Forecast by Market Segment
U.K., All Market Segments Major Tumor Marker Test Volume Forecast
U.K., Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
U.K., Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
U.K., Total Tumor Marker Sales Forecast by Market Segment
U.K., All Market Segments Major Tumor Marker Sales Forecast by Test
U.K., Hospital Laboratories Major Tumor Marker Sales Forecast by Test
U.K., Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
U.K., ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., AFP Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Beta    2 Microglobulin Test Volumeand Diagnostics Sales Forecast by Market Segment
U.K., CA 15 3/27.29 Test Volumeand Diagnostics Sales Forecast by Market Segment
U.K., CA 199 Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Calcitonin Test Volumeand Diagnostics Sales Forecast by Market Segment
U.K., CEA Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Colon    Specific Antigen Test Volume And Diagnostics Sales by Market Segment
U.K., Cytokeratins Test Volumeand Diagnostics Sales Forecast by Market Segment
U.K., Estrogen Receptor Test Volumeand Diagnostics Sales Forecast by Market Segment
U.K., Ferritin Test Volumeand Diagnostics Sales Forecast by Market Segment
U.K., Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., HCG Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Lymphocyte Subtyping Test Volumeand Diagnostics Sales Forecast by Market Segment
U.K., NSE Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Occult Blood Test Volumeand Diagnostics Sales Forecast by Market Segment
U.K., Oncogenes Test Volumeand Diagnostics Sales Forecast by Market Segment
U.K., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., PAP Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., PSA Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., S    100 Protein Test Volumeand Diagnostics Sales Forecast by Market Segment
U.K., Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Sialic Acid Test Volumeand Diagnostics Sales Forecast by Market Segment
U.K., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., TDT Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., TPA Test Volume and Diagnostics Sales Forecast by Market Segment
U.K., Total Tumor Marker Salesand Market Shares Forecast
U.K., CEA Testing Market Diagnostics Sales by Major Supplier
U.K., PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table: U.S., Total Tumor Marker Test Volume and Sales Forecast By Market Segment
U.S., Estimated New Cancer Cases and Deaths
U.S., Estimated Cancer Death Rates Per 100, 000 Population
U.S., Laboratories Performing Tumor Marker Tests by Market Segment
U.S., Hospital Laboratories Performing Tumor Marker Tests by Bed Size
U.S., Commercial/Private Laboratories Performing Tumor Marker Tests By Annual Test Volume
U.S., Physician Office Laboratories Performing Tumor Marker Tests by Practice Size
U.S., Total Tumor Marker Test Volume Forecast by Market Segment
U.S., All Market Segments Major Tumor Marker Test Volume Forecast
U.S., Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
U.S., Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
U.S., Physician Offices/Group Practices Major Tumor Marker Test Volume Forecast
U.S., Cancer Clinics Major Tumor Marker Test Volume Forecast by Test
U.S., Total Tumor Marker Sales Forecast by Market Segment
U.S., All Market Segment Major Tumor Marker Sales Forecast by Test
U.S., Hospital Laboratories Major Tumor Marker Sales Forecast by Test
U.S., Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
U.S., Physician Offices/Group Practices Major Tumor Marker Sales Forecast by Test
U.S., Cancer Clinics Major Tumor Marker Sales Forecast by Test
U.S., ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., AFP Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Beta    2 Microglobulin Test Volumeand Diagnostics Sales Forecast by Market Segment
U.S., CA 15 3/27.29 Test Volumeand Diagnostics Sales Forecast by Market Segment
U.S., CA 199 Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Calcitonin Test Volumeand Diagnostics Sales Forecast by Market Segment
U.S., Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., CEA Test Volume and Diagnostics Sales by Market Segment
U.S., Chromogranin Test Volumeand Diagnostics Sales Forecast by Market Segment
U.S., Colon    specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
U.S., Cytokeratins Test Volume And Diagnostics Sales Forecast by Market Segment
U.S., Estrogen Receptor Test Volume And Diagnostics Sales Forecast by Market Segment
U.S., Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., HCG Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Interferons Test Volume And Diagnostics Sales Forecast by Market Segment
U.S., Interleukins Test Volume And Diagnostics Sales Forecast by Market Segment
U.S., Lymphocyte Subtyping Test Volumeand Diagnostics Sales Forecast by Market Segment
U.S., NSE Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Occult Blood Test Volume And Diagnostics Sales Forecast by Market Segment
U.S., Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., PAP Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., PSA Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., S    100 Protein Test Volumeand Diagnostics Sales Forecast by Market Segment
U.S., Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., TDT Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., TPA Test Volume and Diagnostics Sales Forecast by Market Segment
U.S., Total Tumor Marker Sales By Major Supplier
U.S., ACTH Testing Market Diagnostics Sales by Major Supplier
U.S., AFP Testing Market Diagnostics Sales by Major Supplier
U.S., Beta    2 Migroblolulin Testing Market Diagnostics Sales by Major Supplier
U.S., CA 15 3/27.29 Testing Market Diagnostics Sales by Major Supplier
U.S., CA 199 Testing Market Diagnostics Sales by Major Supplier
U.S., CA 125 Testing Market Diagnostics Sales by Major Supplier
U.S., CEA Testing Market Diagnostics Sales by Major Supplier
U.S., Ferritin Testing Market Diagnostics Sales by Major Supplier
U.S., HCG Testing Market Diagnostics Sales by Major Supplier
U.S., Insulin Testing Market Diagnostics Sales by Major Supplier
U.S., Parathyroid Hormone Testing Market Diagnostics Sales by Major Supplier
U.S., PAP Testing Market Diagnostics Sales by Major Supplier
U.S., Progesterone Receptor Testing Market Diagnostics Sales by Major Supplier
U.S., PSA Testing Market Diagnostics Sales by Major Supplier
Skip to top


Ask Your Question

Competing in the Global Cancer Diagnostics Market, 2017-2021
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: